Phase I and pharmacokinetic study of sorafenib, an oral multikinase inhibitor, in Japanese patients with advanced refractory solid tumors. [electronic resource]
Producer: 20080617Description: 1492-8 p. digitalISSN:- 1349-7006
- Adult
- Aged
- Antineoplastic Agents -- therapeutic use
- Benzenesulfonates -- adverse effects
- Extracellular Signal-Regulated MAP Kinases -- metabolism
- Female
- Fluorodeoxyglucose F18
- Humans
- Male
- Middle Aged
- Neoplasms -- drug therapy
- Niacinamide -- analogs & derivatives
- Phenylurea Compounds
- Phosphorylation
- Positron-Emission Tomography
- Protein Kinase Inhibitors -- therapeutic use
- Pyridines -- adverse effects
- Sorafenib
No physical items for this record
Publication Type: Clinical Trial, Phase I; Journal Article
There are no comments on this title.
Log in to your account to post a comment.